ArticleMedicine2025

TLR2, CCR1, IRF8, and CCL4 as biomarkers for atherosclerosis progression and therapy response: A multi-omics study.

Wangwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.